In patients undergoing percutaneous coronary interventions (PCI) for significant coronary artery disease (CAD), AI-based quantitative coronary angiography (AI-QCA) is non-inferior to optical coherence tomography (OCT) guided PCI, according to results from the FLASH trial.
Under-expansion is a potential factor in clinical outcomes for patients with severe, symptomatic aortic stenosis (AS) receiving the ACURATE neo2 valve, results from the head-to-head ACURATE IDE trial show.
Transcatheter tricuspid valve replacement (TTVR) with the EVOQUE system led to substantial quality of life improvements for severe tricuspid regurgitation (TR) patients versus optimal medical therapy (OMT) alone, according to a new 1-year analysis of the TRISCEND II pivotal trial.
The ACCESS-TAVI trial revealed a significant reduction in both major and minor access site-related vascular complications with the combined suture and plug-based strategy compared to the suture-only strategy.
While colchicine shows promise in mitigating inflammation-driven complications after transcatheter aortic valve replacement (TAVR), researchers in the Co-STAR trial urge a “cautious, tailored approach” to its use due to associated stroke risks.
MagicTouch sirolimus-coated balloons are non-inferior for both safety and efficacy endpoints compared to paclitaxel-coated balloons, reports new SIRONA trial data in patients with femoropopliteal artery disease.
Large-bore mechanical thrombectomy (LBMT) shows significant benefits for clinical outcomes versus catheter-directed thrombolysis (CDT) in intermediate-risk pulmonary embolism (PE) patients in the PEERLESS study.
According to new results from the CLEAR SYNERGY (OASIS 9) trial, acute and long-term colchicine use does not reduce cardiovascular (CV) death, myocardial infarction (MI), stroke or ischemia-driven revascularization patients with acute MI.
Routine orbital atherectomy did not enhance minimal stent area (MSA) or reduce target vessel failure (TVF) at one year compared to conventional balloon angioplasty in the preparation of severely calcified coronary lesions before drug-eluting stent (DES) implantation in the large-scale, randomized ECLIPSE trial.
The bioadaptor proved superior to contemporary drug-eluting stents (DES) in patients undergoing percutaneous coronary intervention (PCI) according to the INFINITY-SWEDEHEART trial, with results presented by David Erlinge, MD, PhD, at the 2024 Transcatheter Cardiovascular Therapeutics (TCT) conference in Washington, DC on Monday.
Lior Lupu, MD, MBA, CRTonline.org
Waiel Abusnina, MD, CRTonline.org
Nathan Gray, CRTonline.org
Will Chu, CRTonline.org
Abhishek Chaturvedi, MD, CRTonline.org
Dan Haberman, MD, CRTonline.org
Bailey G. Salimes, CRTonline.org
Michael Mahmoudi, MD - R Hahn, et al. NEJM 2024 Online
Michael Mahmoudi, MD - B Anderson, et al.; Lancet 2024 Online
Michael Mahmoudi, MD - P Genereux, et al.; NEJM 2024 Online
Michael Mahmoudi, MD - V Kunadian, et al.; NEJM 2024 Online
Recor
BUSINESS WIRE
Do you believe that the guidelines regarding imaging-guided PCI should change?
Yes, Class IA
No, we need more data
Yes, but only for complex lesions
Wilbert Huang, Samuel Flindy, Apridya Nurhafizah, Khairiya Alya Nafisa, Alvin Frederich and Januar Wibawa Martha
Sahar Samimi, Taha Hatab, Chloe Kharsa, Rody G. Bou Chaaya, Fatima Qamar, Safi U. Khan, Joe Aoun, Syed Zaid, Nadeen Faza, Stephen H. Little, Marvin D. Atkins, Michael J. Reardon, Neal S. Kleiman, William A. Zoghbi and Sachin S. Goel
Chukwuma Azoba, Jonte D. Jefferson, Ashley P. Oliver, Emily Brennan, Mohanad R. Youssef, Elizabeth B. Habermann, Kristine T. Hanson, David O. Warner, Kirsten Sell-Dottin and Adam J. Milam
Deniz Mutlu, Bahadir Simsek, Athanasios Rempakos, Michaella Alexandrou, Ahmed Al-Ogaili, Lorenzo Azzalini, Stephane Rinfret, Jaikirshan J. Khatri, Khaldoon Alaswad, Farouc A. Jaffer, Wissam Jaber, Mir B. Basir, Omer Goktekin, Sevket Gorgulu, Oleg Krestyaninov, Dmitrii Khelimskii, Rhian Davies, Jarrod Frizzel, James W. Choi, Raj H. Chandwaney, Srinivasa Potluri, Paul Poommipanit, Barry Uretsky, Luiz F. Ybarra, Bilal Murad, Bavana V. Rangan, Olga C. Mastrodemos, Yader Sandoval, M. Nicholas Burke and Emmanouil S. Brilakis
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details